Individual and healthcare supply-related barriers to treatment initiation in HIV-positive patients enrolled in the Cameroonian antiretroviral treatment access programme.


Journal

Health policy and planning
ISSN: 1460-2237
Titre abrégé: Health Policy Plan
Pays: England
ID NLM: 8610614

Informations de publication

Date de publication:
26 Mar 2021
Historique:
accepted: 28 10 2020
pubmed: 29 12 2020
medline: 29 7 2021
entrez: 28 12 2020
Statut: ppublish

Résumé

Increasing demand for antiretroviral treatment (ART) together with a reduction in international funding during the last decade may jeopardize access to ART. Using data from a cross-sectional survey conducted in 2014 in 19 HIV services in the Centre and Littoral regions in Cameroon, we investigated the role of healthcare supply-related factors in time to ART initiation in HIV-positive patients eligible for ART at HIV diagnosis. HIV service profiles were built using cluster analysis. Factors associated with time to ART initiation were identified using a multilevel Cox model. The study population included 847 HIV-positive patients (women 72%, median age: 39 years). Median (interquartile range) time to ART initiation was 1.6 (0.5-4.3) months. Four HIV service profiles were identified: (1) small services with a limited staff practising partial task-shifting (n = 4); (2) experienced and well-equipped services practising task-shifting and involving HIV community-based organizations (n = 5); (3) small services with limited resources and activities (n = 6); (4) small services providing a large range of activities using task-shifting and involving HIV community-based organizations (n = 4). The multivariable model showed that HIV-positive patients over 39 years old [hazard ratio: 1.26 (95% confidence interval) (1.09-1.45), P = 0.002], those with disease symptoms [1.21 (1.04-1.41), P = 0.015] and those with hepatitis B co-infection [2.31 (1.15-4.66), P = 0.019] were all more likely to initiate ART early. However, patients in the first profile were less likely to initiate ART early [0.80 (0.65-0.99), P = 0.049] than those in the second profile, as were patients in the third profile [association only significant at the 10% level; 0.86 (0.72-1.02), P = 0.090]. Our findings provide a better understanding of the role played by healthcare supply-related factors in ART initiation. In HIV services with limited capacity, task-shifting and support from community-based organizations may improve treatment access. Additional funding is required to relieve healthcare supply-related barriers and achieve the goal of universal ART access.

Identifiants

pubmed: 33367696
pii: 6050511
doi: 10.1093/heapol/czaa153
doi:

Substances chimiques

Anti-HIV Agents 0

Types de publication

Journal Article

Langues

eng

Pagination

137-148

Investigateurs

G Maradan (G)
A Ambani (A)
O Ndalle (O)
P Momo (P)
C Tong (C)
S Boyer (S)
V Boyer (V)
L March (L)
M Mora (M)
L Sagaon-Teyssier (L)
M de Sèze (M)
B Spire (B)
M Suzan-Monti (M)
C Laurent (C)
F Liégeois (F)
E Delaporte (E)
V Boyer (V)
S Eymard-Duvernay (S)
F Chabrol (F)
E Kouakam (E)
O Ossanga (O)
H Essama Owona (H)
C Biloa (C)
M-T Mengue (MT)
E Mpoudi-Ngolé (E)
P J Fouda (PJ)
C Kouanfack (C)
H Abessolo (H)
N Noumssi (N)
M Defo (M)
H Meli (H)
Z Nanga (Z)
Y Perfura (Y)
M Ngo Tonye (MN)
O Kouambo (O)
U Olinga (U)
E Soh (E)
C Ejangue (C)
E Njom Nlend (E)
A Simo Ndongo (A)
E Abeng Mbozo'o (E)
M Mpoudi Ngole (M)
N Manga (N)
C Danwe (C)
L Ayangma (L)
B Taman (B)
E C Njitoyap Ndam (EC)
B Fangam Molu (B)
J Meli (J)
H Hadja (H)
J Lindou (J)
J M Bob Oyono (JM)
S Beke (S)
D Eloundou (D)
G Touko (G)
J J Ze (JJ)
M Fokoua (M)
L Ngum (L)
C Ewolo (C)
C Bondze (C)
J D Ngan Bilong (JD)
D S Maninzou (D)
A Nono Toche (A)
M Tsoungi Akoa (M)
P Ateba (P)
S Abia (S)
A Guterrez (A)
R Garcia (R)
P Thumerel (P)
E Belley Priso (E)
Y Mapoure (Y)
A Malongue (A)
A P Meledie Ndjong (AP)
B Mbatchou (B)
J Hachu (J)
S Ngwane (S)
J Dissongo (J)
M Mbangue (M)
Ida Penda (I)
H Mossi (H)
G Tchatchoua (G)
Yoyo Ngongang (Y)
C Nouboue (C)
I Wandji (I)
L Ndalle (L)
J Djene (J)
M J Gomez (MJ)
A Mafuta (A)
M Mgantcha (M)
E H Moby (EH)
M C Kuitcheu (MC)
A L Mawe (AL)
Ngam Engonwei (N)
L J Bitang (LJ)
M Ndam (M)
R B Pallawo (RB)
Issiakou Adamou (I)
G Temgoua (G)
C Ndjie Essaga (C)
C Tchimou (C)
A Yeffou (A)
I Ngo (I)
H Fokam (H)
H Nyemb (H)
L R Njock (LR)
S Omgnesseck (S)
E Kamto (E)
B Takou (B)
L J-G Buffeteau (LJ)
F Ndoumbe (F)
J-D Noah (JD)
I Seyep (I)

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press in association with The London School of Hygiene and Tropical Medicine. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Pierre-Julien Coulaud (PJ)

Aix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, Faculté de Médecine, 27 Bd Jean Moulin, 13385 Marseille, Cedex 5, France.

Camélia Protopopescu (C)

Aix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, Faculté de Médecine, 27 Bd Jean Moulin, 13385 Marseille, Cedex 5, France.

Khadim Ndiaye (K)

Aix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, Faculté de Médecine, 27 Bd Jean Moulin, 13385 Marseille, Cedex 5, France.

Maël Baudoin (M)

Aix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, Faculté de Médecine, 27 Bd Jean Moulin, 13385 Marseille, Cedex 5, France.

Gwenaëlle Maradan (G)

Aix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, Faculté de Médecine, 27 Bd Jean Moulin, 13385 Marseille, Cedex 5, France.
ORS PACA, Observatoire régional de la santé Provence-Alpes-Côte d'Azur, Faculté de Médecine, 27 Bd Jean Moulin, 13385 Marseille Cedex 5, France.

Christian Laurent (C)

Institut de Recherche pour le Développement, Inserm, Univ Montpellier, TransVIHMI, 911 avenue Agropolis, BP 64501, 34394 Montpellier, Cedex 5, France.

Bruno Spire (B)

Aix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, Faculté de Médecine, 27 Bd Jean Moulin, 13385 Marseille, Cedex 5, France.

Laurent Vidal (L)

Aix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, Faculté de Médecine, 27 Bd Jean Moulin, 13385 Marseille, Cedex 5, France.

Christopher Kuaban (C)

Faculty of Medicine and Biomedical Sciences, University of Yaoundé, Po. Box 1364 Yaoundé, Cameroon.

Sylvie Boyer (S)

Aix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, Faculté de Médecine, 27 Bd Jean Moulin, 13385 Marseille, Cedex 5, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH